Background. Although changes in contractility are often accompanied by changes in relaxation, a mathematical model of ventricular coupling has not been described. A model we examined suggests a hyperbolic relation between measurements of contraction and relaxation. We thus tested the hypothesis
P revious investigators have suggested that relaxation is controlled by three factors: load, inactivation, and nonuniform distribution of load and inactivation in space and in time.'-7 Although several investigators have observed either in vitro8-13 or in vivo'4-16 changes in relaxation occurring concomitantly with changes in contractility (induced by either fl-agonist or Cal' therapy), a firm relation between changes in contractility and alterations in relaxation has not been defined. We hypothesized that the inotropic and lusitropic states of a heart are coupled such that a change in one might predict a change in the other. The most likely reasons to suspect this is true are that 1) both contraction and relaxation are modulated primarily by sarcolemmal and sarcoplasmic calcium flux and cyclic AMP (cAMP) (which is in turn modulated by 3-adrenergic, vasoactive intestinal peptide, histamine, adenosine, and muscurinic pathways)'7 and 2) increased contractility can result in heightened systolic deformation of elastic structures with creation of more prediastolic potential energy that may be released during isovolumic relaxation."14 As the former plays a dominant role in determining relaxation rates' and as congestive heart failure is associated with defects in both the /-adrenergicadenylate cyclase system'8 and intracellular calcium handling, 19 we postulated that changes in inotropic state in normal hearts might not result in the same changes in relaxation as in dysfunctional hearts.
Because of these common pathways that are known to modulate intracellular events and the previous observations of altered contraction and relaxation to inotropic stimulation, we attempted to develop a physiological construct of the contraction-relaxation relation. We hypothesized that contraction and relaxation are coupled events, and we reasoned that changes in adrenergic tone (which regulates calcium flux via cAMP) may alter coupling in a different fashion from digitalis preparations (which regulate calcium flux via Na,K-ATPase).
Methods

Theoretical Considerations
As contraction and relaxation are load-dependent events, we attempted to eliminate this variable by evaluating a mathematical model to relate these two states to each other using two relatively load-independent indexes. End-systolic elastance (Ees) is a relatively load-independent measurement of contractility. [20] [21] [22] However, to assess relaxation in a relatively load-independent fashion, we measured isovolumic relaxation (ir See p 2326 or T) at multiple afterloads. The slope of the r-to-endsystolic pressure (Pes) relation (R) is a relatively loadindependent measure of relaxation as r is reasonably preload independent.5 Thus, with load accounted for, the major determinants of changes in relaxation were inactivation and nonuniform distribution of load and inactivation in space and in time. To To determine the effect of a cAMP-dependent intervention on ventricular coupling, seven of these patients were studied twice, both before and after long-term therapy with the f3-adrenergic blocker bucindolol. The overall hemodynamic results from these patients have been previously reported. 23 No patient was chosen who had a large dyskinetic or an aneurysmal regional wall motion abnormality or evidence of primary valvular heart disease. To determine the effect of a cAMP-independent intervention on ventricular coupling, 12 other patients with heart failure underwent assessment of Ees and R before and immediately after acute infusion of a rapid digitalis preparation, deslanoside. Written After these measurements were recorded, loading conditions were altered while maintaining atrial pacing. Intravenous sodium nitroprusside was initiated at a dose of 0.25-0.50 ,g/kg/min and increased by 0.25 gg/kg/min every 2-5 minutes to achieve a reduction of 10-20 mm Hg in aortic Pes. Care was used to avoid symptomatic hypotension. Repeat hemodynamics and ventriculography were performed at one (two patients) or two (28 patients) time points after aortic Pes had been altered. There was a delay of at least 10 minutes between ventriculograms to allow the left ventricle to return to equilibrium.
For the seven patients who returned after 3 months of f3-adrenergic blocker therapy, the same procedure was used with care to match the original atrially paced heart rate used in the baseline study.
Hemodynamic Protocol for the Group Receiving Digitalis
The effect of deslanoside on the coupling relation was evaluated in an additional 12 patients by using a slightly different protocol. Atrial pacing was again maintained throughout the study at 15 min' above baseline rate.
Hemodynamics were measured at baseline, followed by left ventriculography as previously detailed. One dose of nitroprusside was administered (instead of two), and measurements were repeated. The nitroprusside was then discontinued, and pressure was allowed to return to baseline. Deslanoside (0.8 mg; Sandoz Pharmaceuticals Corp., East Hanover, N.J.) was administered intravenously followed by a 30-minute waiting period for onset of action. This was followed by repeat hemodynamics and left ventriculography both before and after repeat nitroprusside administration.
Data Analysis
Left ventricular volumes were measured by analysis of digital left ventriculography. The cardiac cycle selected was not a premature beat or postpremature beat. Analysis of the cardiac cycle was performed by computer gating of the RR interval into 33 -msec segments. Each cardiac image in the cycle underwent light-pen digitization by a blinded observer. Left ventricular volumes, including end-diastolic, end-systolic, and stroke volumes, were determined by a standard angiographic area-length method.27,28 End diastole applied to the largest ventricular volume (near the peak of the R wave) and end systole was taken as the smallest volume in each cardiac cycle and usually corresponded with the left upper corner of the pressure-volume loop. Simultaneous left ventricular pressure recordings were interfaced directly onto the digital volume assessment at each data point in the cardiac cycle. The ADAC digital computer plotted simultaneous pressure and volume for all data points in the cardiac cycle.
Intraobserver and interobserver variabilities of our digital ventriculogram measurements were tested by repeated analysis of 21 digital left ventricular volumes. The SEE for intraobserver measurements was 4.5 ml (n=21, r=0.99, y=0.86x+25.8, p=0.0001), and the SEE for interobserver measurements was 4.8 ml (n=21, r=0.99, y=0.97x-3.7, p=0.0001).
A regression analysis of the Pes volume points was made for each patient. The slope of this relation was the Ees. A regression analysis of the r-to-Pes relation was also determined with the slope designated as R.
Statistics
Based on the mathematical model of a hyperbolic relation, nonlinear regression models were fit to the data. An ANCOVA approach was used to evaluate the significance of an additive displacement in the coupling constant (k) between groups of patients or patients treated under different conditions. To determine the independent significance of changes in Ees or R after an intervention (either /3-blockade or deslanoside), a paired Student's t test was used. Results of statistical tests were considered significant when the observed probability value was less than 0.05. Results are expressed as mean-±1 SD.
Results
As can be seen in Figure 1 , the relation of r to Pes is linear. In these three representative patients with varying left ventricular function, there were strong correla- tions between r and Pes. Thus, our use of the slope of this relation (R) as a reflection of relaxation (or the load dependence of r) is justified. As R increases, the afterload dependence of r increases. It is clear from Figure 1 that just reporting isovolumic relaxation times as a measure of relaxation is inadequate in patients with increased R values, as r is afterload (and heart rate) dependent. However, as r is relatively insensitive to preload,4'5 R represents a relatively load-independent measurement of isovolumic relaxation (assuming constant heart rate). A plot of the data relating Ees to R for our initial validation studies in 30 subjects can be seen in Figure 2 . As is evident, there was a hyperbolic relation between Ees and the slope of the r-to-Pes relation (r=0.79, p<0.OOl). The (Figure 3) . As is evident in Figure 3 , a hyperbolic relation was maintained. This is not unexpected based on Equation 2 of our theoretical considerations as r at any Pes will be a function of R. This suggests that R not only reflects afterload dependence of the relaxation rate but also reflects the actual relaxation rate corrected for afterload. Thus, it is a relatively load-independent measurement of relaxation. We further compared r70 with the load-dependent measure of contractility, left ventricular ejection fraction (Figure 4) . This relation demonstrates a sharp decline in lusitropy below an ejection fraction of 0.30 in most cases. , samepatients after p-blockade. As P-blockade improves both relaxation and contractility yet does so without shifting to a new curve, coupling is maintained.
Effect of Long-term 8-Adrenergic Blockade on Coupling
Long-term treatment with p-adrenergic blockers was assessed in seven patients with severe heart failure. This therapy resulted in an improvement in contractility (i.e., an increase in elastance) and relaxation (i.e., a reduction in load dependance of isovolumic relaxation). In these patients, Ees increased from 0.47±0.14 to 1.18±0.44 mmHg/ml after 3 months of p-blockade (p=0.008), whereas R decreased from 1.45±0.89 to 0.59±0.27 msec/mm Hg (p=0.03). As elastance increased and R decreased, this resulted in a shift in both Ees and R along the curve (Ees)(R)=0.64 ( Figure 5) Figure 7 , the baseline value for R influenced the change in R after intervention. As the relation of Ees to R is hyperbolic, at low Ees values (high R values), the curve is most steep. Thus, the most marked changes in R can be seen for any change in Ees.
Discussion
These data suggest that contraction and relaxation may be coupled but not in a linear fashion. As heart failure progresses and contractility worsens, relaxation is relatively well preserved until severe systolic dysfunc- (Figure 1 ). This may explain why other investigators have not found an effect of digitalis on myocardial relaxation. However, in patients with normal or near-normal contractility, R approaches 0, and r does not need to be corrected for load as relaxation is relatively load independent. Based on Figure 4 , we would recommend correction of r for afterload in any patient with an ejection fraction less than 0.30.
Previous Investigation Into Physiological Coupling
Previous investigators who have tried to examine changes in contraction-relaxation coupling have observed variable coupling relations. Parmley and Sonnenblick9 found a decrease in the time required for tension to fall to one half its peak value in cat papillary muscle after isoproterenol, but for an equal increase in developed tension, calcium increased relaxation time. Karliner et a129 had similar findings in conscious dogs, although calcium decreased (not increased) isovolumic relaxation time. These data suggest that isoproterenol may acutely shift the relation down the hyperbolic curve in a similar fashion as long-term fl-blockade. However, calcium infusion may shift the entire hyperbola upward. Cohn and coworkers8 found that isoproterenol or calcium infusions in anesthetized dogs increased peak positive dP/dt disproportionately to peak negative dP/ dt, whereas Grassi de Gende et al12 and Mattiazzi et al"l reported the opposite effect of isoproterenol (i.e., contractility affected less than relaxation). These data are not inconsistent with our findings that moderately healthy or healthy hearts (i.e., hearts with elastance values of 0.8-3.0 mm Hg/ml) may be on the flat portion of the hyperbola such that a large increase in contractility may be accompanied by only small changes in isovolumic relaxation times. This is exemplified by a hypothetical patient with an Ees of 1.5 mm Hg/ml, a r of 20-40 msec, and a peak negative dP/dt of 1,500 mm Hg/ sec. Relaxation times and peak negative dP/dt cannot improve much beyond this, whereas Ees may increase significantly. On the other hand, severely failing hearts may have large changes in relaxation with smaller changes in contractility.
Skomedal et al10 found that a-adrenergic stimulation increases isometric contraction and relaxation equally, whereas ,B-agonists effected larger changes in relaxation compared with contraction. These data suggest that a-agonists may not shift the hyperbola, although species differences prevent firm conclusions.1"'18
Parker and Colucci30 found a markedly attenuated inotropic response (measured by a percentage change in peak +dP/dt) to intracoronary dobutamine in heart failure compared with normal hearts. This finding may result from fl-receptor subsensitivity in congestive heart failure.31 These investigators also found a greater decrease in isovolumic relaxation times in the heart failure group compared with patients with normal hearts. This would have been especially true had they corrected isovolumic relaxation times for an increase in systolic pressure seen only in the heart failure patients. Our data agree with these findings. Assuming constant coupling between Ees and R, patients with congestive heart failure who have impaired relaxation at baseline and are on the ascending limb of the hyperbola would be expected to have larger lusitropic improvements with smaller inotropic changes when cAMP is increased with a fl-agonist. Little and coworkers16 found improvements in maximal elastance (Em.x) and a reduction in X with the fl-agonist dobutamine in canine hearts. However, similar to our results in humans, they found improvements in Emaxwith ouabain without a change in r. Although Little et al did not correct the measurements of 7 for loading conditions or relate contraction and relaxation in a relatively load-independent fashion, the ventricles studied were normal, thus not requiring load correction. However, Little et al may have not seen an effect of digitalis on relaxation because the ventricles studied were normal (with a low R value). As seen in Figure 7 , in ventricles with low baseline R values, R changes little with digitalis. Little et al's study in animals and our study in humans suggest that agents that act through fl-receptors and cAMP (either dobutamine acutely or fl-blockers chronically) alter both contraction and relaxation. In addition, our study demonstrated that the amount of alteration in contractility and relaxation was dependent on the degree of left ventricular dysfunction present during the baseline state (i.e., before intervention).
Possible Mechanisms for These Phenomena
It is unclear why lusitropy is well preserved until significant systolic dysfunction appears. As both contractility and relaxation are controlled by calcium flux within the myocyte, one possible mechanism may be alterations in intracellular calcium handling. It has been well documented that intracellular calcium transients are markedly prolonged in congestive heart failure.32-37 One might speculate that calcium "overload" due to the inability of sarcoplasmic reticulum to take up cytosolic calcium does not occur until significant impairment of contractility occurs, at which point relaxation is affected. Although this hypothesis is attractive, a relation of altered calcium transients to functional changes in myocardial contractility and relaxation has not been established. In In addition, we took end systole to be end ejection. Although maximal elastance, in theory, occurs at the instant of the maximum left ventricular pressure-volume relation, in the absence of valvular heart disease the temporal relation between end systole and end ejection is very close. 45, 46 Because patients with congestive heart failure have dilated left ventricles with altered geometry, the geometric assumption of a prolate spheroid for single-plane ventriculography28 may result in some error of volume measurement. This may be especially true in the present study as we used nitroprusside to alter loading conditions. Nitroprusside may result in some geometrical alterations as ventricular volumes decrease and could introduce an error into the volume calculations. Although we produced three pressure-volume loops for 28 of 30 patients who did not receive deslanoside, we only produced two pressurevolume loops for the 12 patients who received deslanoside. The reason for the latter was the dye limitation of four ventriculograms (two pressure-volume loops before deslanoside and two loops after deslanoside) in patients undergoing concomitant coronary angiography. Thus, the error in absolute Ees measurement will be greatest in the deslanoside patients. However, as these patients were compared with themselves using nitroprusside before and after deslanoside and as these ventricles were large, the error of calculation resulting from geometric alterations should be of minimal significance. The use of nitroprusside may also result in some baroreflex-mediated changes in contractility.45 However, as patients with congestive heart failure have high neurosympathetic tone at basebe of minimal significance. In addition, no patient overdrove their atrial pacemaker, suggesting minimal reflex.
Using a previously validated24 method of measuring r, we chose to measure isovolumic relaxation from peak -dP/dt (t=O) to a pressure equal to left ventricular end-diastolic pressure of the following beat. Although some conventions are to measure this regression from peak -dP/dt to 5 or 10 mmHg above end-diastolic pressure to avoid problems with the mitral valve opening, we feel that this had minimal effect on our results as we chose to use only beats with a regression r value of 20.95. Had mitral opening affected dP/dt versus (P-PB), the relation would not have remained linear.
The algebraic derivation for our mathematical model proposed that (Ees)(R)=k where k=(r-TO)/(Ves-VO).
We were concerned whether we could assume that k was constant, as all four of these terms (r, To, Ves, and V0) are variables. However, theoretically, as elastance increases, (Ves-Vo) decreases at a constant Pes. If an increase in elastance indeed produces a decrease in R, then (X-To) will decrease at a constant Pes. Thus, the ratio of (r-To)
to (Ves-Vo) may stay constant. However, as this was not guaranteed, we performed the clinical investigation to validate or disprove this hypothesis. As Figure 2 demonstrates, the assumption is probably valid. Although some data scatter exists in Figure 2 , the relation between Ees and R is probably hyperbolic as the fit is reasonably strong (r=0. Finally, as this mathematical model is asymptotic along the x and y axes, the greatest differences between curves will be near the inflection point of the curves. Thus, differences between curves may be masked by points along two different curves that are not near the inflection point yet are closely aligned to each other. We attempted to find patients who had moderate-to-severe left ventricular dysfunction whose Ees and R values would be close to the inflection points of the curve(s). Thus, we attempted to maximize any differences that we saw between curves.
Conclusions
In conclusion, left ventricular contraction and relaxation may be coupled in humans. According to our mathematical model, a hyperbolic relation may exist between R, a relatively load-independent measure of relaxation, and Ees, a relatively load-independent measure of contractility. This model suggests that myocardial relaxation is relatively preserved until significant left ventricular systolic dysfunction is present. In addition, chronic a-blockade (a cAMP-dependent mechanism) or acute administration of deslanoside (a cAMPindependent mechanism) appears to improve both contraction and relaxation along the hyperbolic curve and does not appear to alter coupling. These findings have important clinical implications regarding therapeutic response in heart failure and selection of patients for clinical trials.
